Dycom Industries, Inc. (NYSE:DY) Expected to Post Earnings of $0.84 Per Share
Wall Street analysts forecast that Dycom Industries, Inc. (NYSE:DY) will announce earnings of $0.84 per share for the current quarter, Zacks Investment Research reports. Six analysts have made estimates...
Aerospace & Defense
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
More »
- Spirit Airlines Cancellations Cause Chaos in Airport
- China’s C919 Completes Maiden Flight
- United Earnings Meet Expectations, But Fall 52%
- Air France to Launch No-Frills Airline For U.S. and Asia
- Delta’s Profit for Second Quarter Rises But Revenue Falls
- Boeing Announces Historic Deal with Iran Air
- JetBlue Planning Mint Service Expansion After Losing Virgin America Bid
- Southwest Wants to Fly Out of Long Beach
Banking
Dycom Industries, Inc. (NYSE:DY) Expected to Post Earnings of $0.84 Per Share
More »
- Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Receives $3.49 Consensus Target Price from Analysts
- LyondellBasell Industries NV (NYSE:LYB) Shares Sold by Freestone Capital Holdings LLC
- $1.25 EPS Expected for Eastgroup Properties Inc (NYSE:EGP) This Quarter
- Zacks: Brokerages Anticipate Veritone Inc (NASDAQ:VERI) to Post -$0.44 EPS
- $0.03 Earnings Per Share Expected for Diana Shipping Inc (NYSE:DSX) This Quarter
- Zacks: Analysts Anticipate Eni SpA (NYSE:E) to Announce $0.63 Earnings Per Share
- Zacks: Brokerages Expect DiamondRock Hospitality (NYSE:DRH) to Announce $0.26 Earnings Per Share
- Freestone Capital Holdings LLC Boosts Stake in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM)
Pharmaceuticals
Shares at Radius Jump as Bone Drug of Amgen Has Setback
More »
- FDA Approves New Treatment for ALS
- Valeant Pharmaceuticals Cuts Debt Following L’Oreal Deal
- FDA Gives Approval to New Powerful Eczema Drug
- Trump Tweet Sends Pharmaceutical Stocks Tumbling
- Shares of Kite Pharma Flying High After Reaching Study Goal
- Pharmaceuticals Shunning Push by Trump for FDA Shift
- Cigna Changes to Generic EpiPen, CVS Cuts Prices
- Pfizer and OPKO Drug for Growth Hormone Deficiency Fails Study
Goods & Commodities
Hyundai and Kia Recall Ordered by South Korea Officials
More »
- Mattel CEO Promises Growth Following Sales Slump
- Burberry Misses Estimates on Sales
- Tesla Deliveries Set Record for One Quarter at 25,000
- FedEx Comes Up Short on Earnings
- Brazil Looks to Calm Fears Over Export and Sale of Meat
- Dollar General Increasing Pay, Lowering Price and Adding Perishable Goods
- Shares of Staples Fall After Earnings Come Up Short
- Opel Sold by General Motors to PSA
Technology
What’s next for technology in entertainment?
More »
- How to Become a Java Developer – Practical Guide
- Super Nintendo World Theme Park Officially Starts Construction
- Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
- Camera Zooms In and Can Recognize Faces
- Netflix Could See 150 Million Worldwide Subscribers
- LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
- Blackberry Returns as Stock Surges Following WannaCry
- General Motors’ Maven Launches in New York City
Energy & Mining
Fuel Shortage in Venezuela Growing Worse
More »
- Oil Prices Drop to Low of Three Months on Rig Count
- The 2016 oil market: a year in review
- What’s next for the oil market as it reaches a critical point?
- Exxon Issues Warning on Reserves After Posting Drop in Profit
- Shell Posts Disappointing Results As Profit Hit by BG Deal and Oil
- DONG Energy Stock Surges After Largest European IPO in 2016
- SunEdison Said to be Preparing to File Bankruptcy
- West Virginia Gives Tax Break to Natural Gas and Coal
Free Email Newsletter
Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:
Follow Ticker Report
Recent Posts
- Dycom Industries, Inc. (NYSE:DY) Expected to Post Earnings of $0.84 Per Share
- Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Receives $3.49 Consensus Target Price from Analysts
- Zacks: Brokerages Anticipate Veritone Inc (NASDAQ:VERI) to Post -$0.44 EPS
- $0.03 Earnings Per Share Expected for Diana Shipping Inc (NYSE:DSX) This Quarter
- $1.25 EPS Expected for Eastgroup Properties Inc (NYSE:EGP) This Quarter
- LyondellBasell Industries NV (NYSE:LYB) Shares Sold by Freestone Capital Holdings LLC
- Zacks: Brokerages Expect DiamondRock Hospitality (NYSE:DRH) to Announce $0.26 Earnings Per Share
- Zacks: Analysts Anticipate Eni SpA (NYSE:E) to Announce $0.63 Earnings Per Share
- Freestone Capital Holdings LLC Sells 58,851 Shares of F5 Networks, Inc. (NASDAQ:FFIV)
- Freestone Capital Holdings LLC Boosts Stake in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM)
- Brokerages Anticipate Employers Holdings, Inc. (NYSE:EIG) to Post $0.52 Earnings Per Share
- Freestone Capital Holdings LLC Cuts Holdings in Philip Morris International Inc. (NYSE:PM)
- $1.63 EPS Expected for Consolidated Edison, Inc. (NYSE:ED) This Quarter
- Analysts Anticipate Eastman Chemical (NYSE:EMN) to Announce $2.00 EPS
- Freestone Capital Holdings LLC Reduces Stock Position in Quest Diagnostics Inc (NYSE:DGX)
- Freestone Capital Holdings LLC Cuts Stake in Orange SA (NYSE:ORAN)
- Analysts Anticipate Adtalem Global Education Inc (NYSE:ATGE) Will Announce Earnings of $0.96 Per Share
- SAP SE (NYSE:SAP) Shares Acquired by Freestone Capital Holdings LLC
- New Oriental Education & Tech Grp (NYSE:EDU) Expected to Post Earnings of $1.38 Per Share
- Prudential Public Limited (NYSE:PUK) Shares Purchased by Freestone Capital Holdings LLC
© 2006-2019 Ticker Report